← Leaderboards
Utpal P Dave
Rlr Va Medical Center
$2,435,124
Attributed
$2,435,124
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $365K · FY2007–25$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,435,124 · 2
VA$0 · 1
By mechanism
R01$1,801,939 · 1
K08$633,185 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteOncogenesMutantLeukemiaAffectMutationPathogenesisGenesPathway InteractionsResistanceProteinsHematopoietic Stem CellsGrantComplexOncogenicMalignant NeoplasmsTransplantationBone MarrowJak3 GeneSignal TransductionFunctional DisorderAcute T Cell LeukemiaCellsLeukemia/Lymphoma
Grant awards (23)
Pathophysiology of Adult T-cell leukemia/lymphoma$0
I01 · FY2025 · VA · contact PI
Pathophysiology of Adult T-cell leukemia/lymphoma$0
I01 · FY2024 · VA · contact PI
Pathophysiology of Adult T-cell leukemia/lymphoma$0
I01 · FY2023 · VA · contact PI
Pathophysiology of Adult T-cell leukemia/lymphoma$0
I01 · FY2022 · VA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2021 · VA · contact PI
The Role of LMO2 in the Pathogenesis of T-cell Leukemia$360,255
R01 · FY2020 · CA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2020 · VA · contact PI
The Role of LMO2 in the Pathogenesis of T-cell Leukemia$349,694
R01 · FY2019 · CA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2019 · VA · contact PI
The Role of LMO2 in the Pathogenesis of T-cell Leukemia$364,962
R01 · FY2018 · CA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2018 · VA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2018 · VA · contact PI
The Role of LMO2 in the Pathogenesis of T-cell Leukemia$364,962
R01 · FY2017 · CA · contact PI
The Role of LMO2 in the Pathogenesis of T-cell Leukemia$362,066
R01 · FY2016 · CA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2016 · VA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2015 · VA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2014 · VA · contact PI
Pathophysiology of Adult T-cell Leukemia/Lymphoma$0
I01 · FY2013 · VA · contact PI
Pathogenesis of SCID-X Gene Therapy - Induced Leukemias$127,686
K08 · FY2011 · HL · contact PI
Pathogenesis of SCID-X Gene Therapy - Induced Leukemias$127,159
K08 · FY2010 · HL · contact PI
Pathogenesis of SCID-X Gene Therapy - Induced Leukemias$126,632
K08 · FY2009 · HL · contact PI
Pathogenesis of SCID-X Gene Therapy - Induced Leukemias$126,104
K08 · FY2008 · HL · contact PI
Pathogenesis of SCID-X Gene Therapy - Induced Leukemias$125,604
K08 · FY2007 · HL · contact PI